Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus Thalidomide | Zendy

Hongsheng Wen | Zendy; Xu Li | Zendy; Yuzhu Cao | Zendy; Cuicui Zhang | Zendy; Fang Yang | Zendy; Yu-Ming Shi | Zendy; Liming Peng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus Thalidomide

Author(s) -

Hongsheng Wen,

Xu Li,

Yuzhu Cao,

Cuicui Zhang,

Fang Yang,

Yu-Ming Shi,

Liming Peng

Publication year - 2012

Publication title -

chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.539

H-Index - 54

eISSN - 1421-9794

pISSN - 0009-3157

DOI - 10.1159/000346446

Subject(s) - medicine , megestrol acetate , cachexia , thalidomide , anorexia , gastroenterology , randomized controlled trial , appetite , weight loss , clinical trial , cancer , obesity , multiple myeloma

The management of cancer-related anorexia/cachexia syndrome (CACS) is a great challenge in clinical practice. To date, practice guidelines for the prevention and treatment of CACS are lacking. The authors conducted a randomized study to confirm the effectiveness and safety of treatment of CACS utilizing megestrol acetate (MA) plus thalidomide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research